PRKAA1 and hepatocellular carcinoma: During the last years, several studies performed in HCC derived cells, show that activation of AMPK by different activators entails either cell cycle arrest, as in the case of AICAR and metformin [12, 13], or cell death, as in the case of cannabinoids and berberine [14, 15].